{"count": 8, "results": [{"_id": "33587350", "pmid": 33587350, "title": "Simvastatin enhances the efficacy of nilotinib in chronic myeloid leukaemia by post-translational modification and drug transporter modulation.", "journal": "Anticancer Drugs", "authors": ["Asari K", "Sun WT", "Kok ZH", "Lam YH", "Ng BL", "Saunders V", "White DL", "Chuah C", "Xiang W"], "date": "2021-06-01T00:00:00Z", "doi": "10.1097/CAD.0000000000001028", "meta_date_publication": "2021 Jun 1", "meta_volume": "32", "meta_issue": "5", "meta_pages": "526-536", "score": 50262.9, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ enhances the efficacy of @CHEMICAL_nilotinib @CHEMICAL_MESH:C498826 @@@nilotinib@@@ in @<m>DISEASE_Leukemia_Lymphocytic_Chronic_B_Cell</m> @DISEASE_MESH:D015451 @@@chronic myeloid leukaemia@@@ by post-translational modification and drug transporter modulation.", "citations": {"NLM": "Asari K, Sun WT, Kok ZH, Lam YH, Ng BL, Saunders V, White DL, Chuah C, Xiang W. Simvastatin enhances the efficacy of nilotinib in chronic myeloid leukaemia by post-translational modification and drug transporter modulation. Anticancer Drugs. 2021 Jun 1;32(5):526-536. PMID: 33587350", "BibTeX": "@article{33587350, title={Simvastatin enhances the efficacy of nilotinib in chronic myeloid leukaemia by post-translational modification and drug transporter modulation.}, author={Asari K and Sun WT and Kok ZH and Lam YH and Ng BL and Saunders V and White DL and Chuah C and Xiang W}, journal={Anticancer Drugs}, volume={32}, number={5}, pages={526-536}}"}}, {"_id": "33335123", "pmid": 33335123, "pmcid": "PMC7746765", "title": "Systems biology drug screening identifies statins as enhancers of current therapies in chronic lymphocytic leukemia", "journal": "Sci Rep", "authors": ["Gimenez N", "Tripathi R", "Giró A", "Rosich L", "López-Guerra M", "López-Oreja I", "Playa-Albinyana H", "Arenas F", "Mas JM", "Pérez-Galán P", "Delgado J", "Campo E", "Farrés J", "Colomer D"], "date": "2020-12-17T00:00:00Z", "doi": "10.1038/s41598-020-78315-0", "meta_date_publication": "2020 Dec 17", "meta_volume": "10", "meta_issue": "1", "meta_pages": "22153", "score": 50258.918, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ decreased @<m>DISEASE_Leukemia_Lymphocytic_Chronic_B_Cell</m> @DISEASE_MESH:D015451 @@@CLL@@@ cell survival and proliferation as well as cell adhesion. ", "citations": {"NLM": "Gimenez N, Tripathi R, Giró A, Rosich L, López-Guerra M, López-Oreja I, Playa-Albinyana H, Arenas F, Mas JM, Pérez-Galán P, Delgado J, Campo E, Farrés J, Colomer D. Systems biology drug screening identifies statins as enhancers of current therapies in chronic lymphocytic leukemia Sci Rep. 2020 Dec 17;10(1):22153. PMID: 33335123", "BibTeX": "@article{33335123, title={Systems biology drug screening identifies statins as enhancers of current therapies in chronic lymphocytic leukemia}, author={Gimenez N and Tripathi R and Giró A and Rosich L and López-Guerra M and López-Oreja I and Playa-Albinyana H and Arenas F and Mas JM and Pérez-Galán P and Delgado J and Campo E and Farrés J and Colomer D}, journal={Sci Rep}, volume={10}, number={1}, pages={22153}}"}}, {"_id": "24162379", "pmid": 24162379, "title": "Pharmacokinetics of high-dose simvastatin in refractory and relapsed chronic lymphocytic leukemia patients.", "journal": "Cancer Chemother Pharmacol", "authors": ["Ahmed TA", "Hayslip J", "Leggas M"], "date": "2013-12-01T00:00:00Z", "doi": "10.1007/s00280-013-2326-3", "meta_date_publication": "2013 Dec", "meta_volume": "72", "meta_issue": "6", "meta_pages": "1369-74", "score": 50069.547, "text_hl": "Pharmacokinetics of high-dose @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ in refractory and relapsed @<m>DISEASE_Leukemia_Lymphocytic_Chronic_B_Cell</m> @DISEASE_MESH:D015451 @@@chronic lymphocytic leukemia@@@ @SPECIES_9606 @@@patients@@@.", "citations": {"NLM": "Ahmed TA, Hayslip J, Leggas M. Pharmacokinetics of high-dose simvastatin in refractory and relapsed chronic lymphocytic leukemia patients. Cancer Chemother Pharmacol. 2013 Dec;72(6):1369-74. PMID: 24162379", "BibTeX": "@article{24162379, title={Pharmacokinetics of high-dose simvastatin in refractory and relapsed chronic lymphocytic leukemia patients.}, author={Ahmed TA and Hayslip J and Leggas M}, journal={Cancer Chemother Pharmacol}, volume={72}, number={6}, pages={1369-74}}"}}, {"_id": "12962723", "pmid": 12962723, "title": "Simvastatin induces apoptosis of B-CLL cells by activation of mitochondrial caspase 9.", "journal": "Exp Hematol", "authors": ["Chapman-Shimshoni D", "Yuklea M", "Radnay J", "Shapiro H", "Lishner M"], "date": "2003-09-01T00:00:00Z", "doi": "10.1016/s0301-472x(03)00192-9", "meta_date_publication": "2003 Sep", "meta_volume": "31", "meta_issue": "9", "meta_pages": "779-83", "score": 50067.28, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ induces apoptosis of @<m>DISEASE_Leukemia_Lymphocytic_Chronic_B_Cell</m> @DISEASE_MESH:D015451 @@@B-CLL@@@ cells by activation of mitochondrial @GENE_CASP9 @GENE_842 @@@caspase 9@@@.", "citations": {"NLM": "Chapman-Shimshoni D, Yuklea M, Radnay J, Shapiro H, Lishner M. Simvastatin induces apoptosis of B-CLL cells by activation of mitochondrial caspase 9. Exp Hematol. 2003 Sep;31(9):779-83. PMID: 12962723", "BibTeX": "@article{12962723, title={Simvastatin induces apoptosis of B-CLL cells by activation of mitochondrial caspase 9.}, author={Chapman-Shimshoni D and Yuklea M and Radnay J and Shapiro H and Lishner M}, journal={Exp Hematol}, volume={31}, number={9}, pages={779-83}}"}}, {"_id": "20499237", "pmid": 20499237, "pmcid": "PMC2940031", "title": "Simvastatin and purine analogs have a synergic effect on apoptosis of chronic lymphocytic leukemia cells", "journal": "Ann Hematol", "authors": ["Podhorecka M", "Halicka D", "Klimek P", "Kowal M", "Chocholska S", "Dmoszynska A"], "date": "2010-11-01T00:00:00Z", "doi": "10.1007/s00277-010-0988-z", "meta_date_publication": "2010 Nov", "meta_volume": "89", "meta_issue": "11", "meta_pages": "1115-24", "score": 50066.895, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ and @CHEMICAL_purine @CHEMICAL_MESH:C030985 @@@purine@@@ analogs have a synergic effect on apoptosis of @<m>DISEASE_Leukemia_Lymphocytic_Chronic_B_Cell</m> @DISEASE_MESH:D015451 @@@chronic lymphocytic leukemia@@@ cells", "citations": {"NLM": "Podhorecka M, Halicka D, Klimek P, Kowal M, Chocholska S, Dmoszynska A. Simvastatin and purine analogs have a synergic effect on apoptosis of chronic lymphocytic leukemia cells Ann Hematol. 2010 Nov;89(11):1115-24. PMID: 20499237", "BibTeX": "@article{20499237, title={Simvastatin and purine analogs have a synergic effect on apoptosis of chronic lymphocytic leukemia cells}, author={Podhorecka M and Halicka D and Klimek P and Kowal M and Chocholska S and Dmoszynska A}, journal={Ann Hematol}, volume={89}, number={11}, pages={1115-24}}"}}, {"_id": "11877052", "pmid": 11877052, "title": "[Inhibition of proliferation and induction of apoptosis by simvastatin in K562 leukemic cell line].", "journal": "Zhonghua Xue Ye Xue Za Zhi", "authors": ["Ren H", "Zhang N", "Xu H", "Lu D"], "date": "2001-02-01T00:00:00Z", "meta_date_publication": "2001 Feb", "meta_volume": "22", "meta_issue": "2", "meta_pages": "72-5", "score": 50065.984, "text_hl": "METHODS: @CELLLINE_CVCL:0004 @@@K562@@@ cell line was used to evaluate the effects of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@, an inhibitor of @GENE_HMGCR @GENE_3156 @@@3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase@@@, and the combination of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ with chemotherapeutic agents on the proliferation and apoptosis of @<m>DISEASE_Leukemia_Lymphocytic_Chronic_B_Cell</m> @DISEASE_MESH:D015451 @@@CML@@@ cells. ", "citations": {"NLM": "Ren H, Zhang N, Xu H, Lu D. [Inhibition of proliferation and induction of apoptosis by simvastatin in K562 leukemic cell line]. Zhonghua Xue Ye Xue Za Zhi. 2001 Feb;22(2):72-5. PMID: 11877052", "BibTeX": "@article{11877052, title={[Inhibition of proliferation and induction of apoptosis by simvastatin in K562 leukemic cell line].}, author={Ren H and Zhang N and Xu H and Lu D}, journal={Zhonghua Xue Ye Xue Za Zhi}, volume={22}, number={2}, pages={72-5}}"}}, {"_id": "9076662", "pmid": 9076662, "title": "Simvastatin impairs mitogen-induced proliferation of malignant B-lymphocytes from humans--in vitro and in vivo studies.", "journal": "Lipids", "authors": ["Vitols S", "Angelin B", "Juliusson G"], "date": "1997-03-01T00:00:00Z", "doi": "10.1007/s11745-997-0032-1", "meta_date_publication": "1997 Mar", "meta_volume": "32", "meta_issue": "3", "meta_pages": "255-62", "score": 50064.25, "text_hl": "Ten previously untreated @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Leukemia_Lymphocytic_Chronic_B_Cell</m> @DISEASE_MESH:D015451 @@@CLL@@@ received @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ orally, 40 mg daily for 12 wk. ", "citations": {"NLM": "Vitols S, Angelin B, Juliusson G. Simvastatin impairs mitogen-induced proliferation of malignant B-lymphocytes from humans--in vitro and in vivo studies. Lipids. 1997 Mar;32(3):255-62. PMID: 9076662", "BibTeX": "@article{9076662, title={Simvastatin impairs mitogen-induced proliferation of malignant B-lymphocytes from humans--in vitro and in vivo studies.}, author={Vitols S and Angelin B and Juliusson G}, journal={Lipids}, volume={32}, number={3}, pages={255-62}}"}}, {"_id": "14612892", "pmid": 14612892, "pmcid": "PMC2394453", "title": "Effects of imatinib mesylate (STI571, Glivec) on the pharmacokinetics of simvastatin, a cytochrome P450 3A4 substrate, in patients with chronic myeloid leukaemia", "journal": "Br J Cancer", "authors": ["O'Brien SG", "Meinhardt P", "Bond E", "Beck J", "Peng B", "Dutreix C", "Mehring G", "Milosavljev S", "Huber C", "Capdeville R", "Fischer T"], "date": "2003-11-17T00:00:00Z", "doi": "10.1038/sj.bjc.6601152", "meta_date_publication": "2003 Nov 17", "meta_volume": "89", "meta_issue": "10", "meta_pages": "1855-9", "score": 50056.66, "text_hl": "In total, 20 @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Leukemia_Lymphocytic_Chronic_B_Cell</m> @DISEASE_MESH:D015451 @@@chronic myeloid leukaemia@@@ received an oral dose of 40 mg of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ on study day 1. ", "citations": {"NLM": "O'Brien SG, Meinhardt P, Bond E, Beck J, Peng B, Dutreix C, Mehring G, Milosavljev S, Huber C, Capdeville R, Fischer T. Effects of imatinib mesylate (STI571, Glivec) on the pharmacokinetics of simvastatin, a cytochrome P450 3A4 substrate, in patients with chronic myeloid leukaemia Br J Cancer. 2003 Nov 17;89(10):1855-9. PMID: 14612892", "BibTeX": "@article{14612892, title={Effects of imatinib mesylate (STI571, Glivec) on the pharmacokinetics of simvastatin, a cytochrome P450 3A4 substrate, in patients with chronic myeloid leukaemia}, author={O'Brien SG and Meinhardt P and Bond E and Beck J and Peng B and Dutreix C and Mehring G and Milosavljev S and Huber C and Capdeville R and Fischer T}, journal={Br J Cancer}, volume={89}, number={10}, pages={1855-9}}"}}]}